Bone Density and Osteoporosis in Menopause: Screening, Prevention and Treatment
Bone loss accelerates after menopause. Here is when to get screened, what the options are, and what to discuss with your clinician.
Nobody told you bones were on the list. You came in with hot flashes and night sweats, and now someone is talking about a DEXA scan and calcium supplements and whether you have risk factors for fractures. The connection between menopause and bone loss is well established, but it is one of those things that tends to arrive as a surprise, usually after the bone density has already started to change.
The plain version: estrogen helps keep bones strong. When estrogen drops during menopause, bone breakdown outpaces bone building, and density declines. The fastest loss happens in the first five to seven years after the final period. Screening with a DEXA scan, weight-bearing exercise, calcium, vitamin D and not smoking are the foundation of prevention. For people with osteoporosis or high fracture risk, medications are available that can slow or partly reverse the loss.
What’s going on
Bone is living tissue. Throughout life, old bone is broken down (resorption) and new bone is built (formation) in a continuous cycle. Estrogen helps regulate this balance by restraining the cells that break bone down. When estrogen levels fall during the menopause transition, resorption speeds up and formation cannot keep pace [6].
Data from the SWAN study, which followed over 2,300 women, showed that bone mineral density loss accelerated sharply in the year before and the two years after the final menstrual period, with the most rapid losses occurring at the spine [6]. Over the full transition, spinal bone density can decline by as much as 10 to 12 percent. The rate slows somewhat after the initial rapid phase but does not return to premenopausal levels.
This bone loss happens silently. There are no symptoms until a fracture occurs, which is why screening matters. Osteoporosis, defined as bone density significantly below the young adult average (a T-score of -2.5 or lower on a DEXA scan), affects a substantial number of postmenopausal people. Osteopenia, the stage between normal density and osteoporosis, is even more common.
Fractures, particularly of the hip, spine and wrist, are the real clinical concern. Hip fractures in older adults carry significant morbidity and mortality. The goal of screening and treatment is to identify people at risk before the first fracture happens.
Is it the change, or something else?
| Typical in menopause | Overlaps with other conditions | Needs prompt attention |
|---|---|---|
| Gradual height loss (more than an inch) | Thyroid disease (hyperthyroidism accelerates bone loss) | Sudden severe back pain after a minor fall or lift |
| DEXA showing bone density decline | Vitamin D deficiency | A fracture from minimal trauma |
| No symptoms until a fracture occurs | Long-term corticosteroid use | Significant height loss or new stooped posture |
| Family history of osteoporosis or hip fracture | Celiac disease or inflammatory bowel disease (affect absorption) | Hip or groin pain after a fall |
Some medications, including certain breast cancer treatments, long-term steroids and some seizure drugs, accelerate bone loss. If you take any of these, earlier screening may be appropriate.
What helps, and how well
Weight-bearing and resistance exercise. Walking, jogging, stair climbing, dancing, lifting weights and similar activities put mechanical stress on bone, which signals the body to maintain or build density. Exercise also improves balance and muscle strength, reducing fall risk, which is at least as important as the bone density effect itself.
How strong is the evidence? Good. Multiple studies support exercise for maintaining bone density and reducing fracture risk, though exercise alone cannot fully counteract menopause-related bone loss.
Calcium and vitamin D. Calcium is the building material; vitamin D helps the body absorb it. General guidance for postmenopausal people is about 1,200 mg of calcium per day from food and supplements combined, and 800 to 1,000 IU of vitamin D [5]. Food sources (dairy, fortified foods, leafy greens for calcium; fatty fish, fortified foods, sunlight for vitamin D) are preferred where possible. Your clinician may check your vitamin D level and adjust the recommendation.
Not smoking. Smoking accelerates bone loss and is a recognized risk factor for osteoporosis and fractures.
Limiting alcohol. Heavy alcohol use is associated with lower bone density. Moderate consumption is less clearly linked, but limiting alcohol supports bone health along with other health goals.
Prescription medications. For people diagnosed with osteoporosis or at high fracture risk, several medication classes are available. Bisphosphonates (such as alendronate and risedronate) are commonly used first-line treatments that slow bone resorption. Other options include denosumab (a different mechanism of slowing resorption), selective estrogen receptor modulators, and anabolic agents that stimulate bone formation. The choice depends on the individual’s risk profile, other health conditions and clinician judgment.
Hormone therapy. Systemic hormone therapy preserves bone density and reduces fracture risk. The WHI found a significant reduction in hip fractures among women taking combined estrogen-progestogen therapy [1]. However, current guidance from The Menopause Society recommends hormone therapy primarily for vasomotor symptoms, with bone protection as an additional benefit rather than the sole indication. For people already taking hormone therapy for symptoms, the bone benefit is a welcome bonus.
Take this to your appointment
- Should I have a DEXA scan? I am [age], and I have [or don’t have] risk factors for osteoporosis.
- What is my T-score, and what does it mean for my fracture risk over the next ten years?
- Am I getting enough calcium and vitamin D? Should we check my vitamin D level?
- I take [medication]. Does it affect my bone density?
- If I have osteopenia, what should I do now, and when should I be rescreened?
- If I need treatment, what are the options and their side effects?
See a clinician promptly if… you have any bleeding after 12 months without a period, very heavy or prolonged bleeding, new chest pain, a painful swollen leg or sudden shortness of breath, or low mood that won’t lift. If you are thinking about harming yourself, call or text 988 in the US, or call 911 in an emergency. This article is general education, not medical advice.
Related reading: Exercise in Menopause: What the Evidence Says About Strength, Cardio and Bone | Hormone Therapy Risks: Put the Headlines in Numbers
Frequently asked questions
When should I get a bone density test?
Standard guidance recommends a DEXA scan at age 65 for women. Earlier screening is recommended if you have risk factors such as early menopause, low body weight, a history of fractures, long-term steroid use, or a parent who had a hip fracture.
Can exercise prevent osteoporosis after menopause?
Weight-bearing and resistance exercise help maintain bone density and reduce fall risk. They cannot fully prevent menopause-related bone loss on their own, but they are an important part of the picture, especially combined with adequate calcium and vitamin D.
Does hormone therapy help with bone loss?
Yes. Systemic hormone therapy helps preserve bone density and reduces fracture risk. However, current guidance recommends it primarily for vasomotor symptoms, with bone protection as a potential additional benefit rather than the sole reason to prescribe it.
How much calcium and vitamin D do I need after menopause?
General guidance suggests 1,200 mg of calcium daily (from food and supplements combined) and 800 to 1,000 IU of vitamin D for postmenopausal people, though your clinician may adjust this based on your levels and overall health.
Sources and further reading
- The Menopause Society — 2022 Hormone Therapy Position Statement
Position statement covering hormone therapy's role in bone preservation during the menopause transition.
- USPSTF — Screening for Osteoporosis to Prevent Fractures
US Preventive Services Task Force recommendation on DEXA screening for postmenopausal women.
- Cauley et al. — Bone mineral density and the risk of incident nonspinal fractures in black and white women
JAMA, 2005;293(17):2102-2108. Study of Women's Health Initiative, 146,959 women, examining bone density and fracture risk.
- NICE NG23 — Menopause: diagnosis and management
UK guideline on menopause management including bone health recommendations.
- NOF — Clinician's Guide to Prevention and Treatment of Osteoporosis
National Osteoporosis Foundation guidance on prevention and pharmacological treatment.
- Greendale et al. — Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort
Journal of Clinical Endocrinology and Metabolism, 2012;97(4):1282-1290. SWAN study, 2,305 women, documenting accelerated bone loss around the final menstrual period.
Sources checked October 19, 2026. This is an editorial summary, not a systematic review or individual advice.